blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1903112

EP1903112 - Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  24.07.2009
Database last updated on 02.11.2024
Most recent event   Tooltip24.07.2009Withdrawal of applicationpublished on 26.08.2009  [2009/35]
Applicant(s)For all designated states
Genetics Institute, LLC
87 CambridgePark Drive
Cambridge, MA 02140 / US
[2008/13]
Inventor(s)01 / Wozney, John M
59 Old Bolton Road Hudson
MA 01749 / US
02 / Celeste, Anthony J
58 Mystic Street Medford
MA 02155 / US
03 / Thies, R. Scott
1053 Riesling Drive Peasanton
CA 94566 / US
04 / Yamaji, Noboru
21 Miyukigaoka Tsukuba-City
Ibaraki 305 / JP
 [2008/13]
Representative(s)Denholm, Anna Marie, et al
Wyeth Pharmaceuticals Huntercombe Lane South Taplow Maidenhead
Berkshire SL6 0PH / GB
[N/P]
Former [2008/13]Denholm, Anna Marie, et al
Wyeth Pharmaceuticals, Huntercombe Lane South Taplow, Maidenhead
Berkshire SL6 0PH / GB
Application number, filing date07016332.407.09.1994
[2008/13]
Priority number, dateUS1993012393417.09.1993         Original published format: US 123934
[2008/13]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1903112
Date:26.03.2008
Language:EN
[2008/13]
Type: A3 Search report 
No.:EP1903112
Date:20.08.2008
[2008/34]
Search report(s)(Supplementary) European search report - dispatched on:EP21.07.2008
ClassificationIPC:C12N15/12, C07K14/71, C07K14/51, C07K16/28, A61K38/18
[2008/13]
CPC:
C07K14/71 (EP,KR,US); C12N15/11 (KR); A61K38/18 (KR);
A61P43/00 (EP); C07K14/51 (EP,US); A61K38/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2008/13]
TitleGerman:Activin-Rezeptoren-ähnliche Kinase, die zur TGF-Rezeptor-Familie und/oder zur BMP-Rezeptor-Familie gehört[2008/13]
English:Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family[2008/13]
French:Kinase analogue à des récepteurs de l'activine, appartenant à la famille des récepteurs de TGF et/ou à la famille des récepteurs des protéines morphogénétiques osseuses[2008/13]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure21.08.2007Examination requested  [2008/13]
25.09.2008Despatch of a communication from the examining division (Time limit: M06)
13.05.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
23.07.2009Application withdrawn by applicant  [2009/35]
Parent application(s)   TooltipEP94928035.8  / EP0723588
Fees paidRenewal fee
21.08.2007Renewal fee patent year 03
21.08.2007Renewal fee patent year 04
21.08.2007Renewal fee patent year 05
21.08.2007Renewal fee patent year 06
21.08.2007Renewal fee patent year 07
21.08.2007Renewal fee patent year 08
21.08.2007Renewal fee patent year 09
21.08.2007Renewal fee patent year 10
21.08.2007Renewal fee patent year 11
21.08.2007Renewal fee patent year 12
21.08.2007Renewal fee patent year 13
21.08.2007Renewal fee patent year 14
27.03.2008Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PX]WO9411502  (LUDWIG INST CANCER RES [GB], et al) [PX] 1,2,4,6-8,29-32,36 * the whole document *;
 [X]  - "H.sapiens ALK-3 mRNA.", EMBL, (19930916), Database accession no. Z22535, URL: EBI, XP002468919 [X] 1,2,4,6-8,29-32,36 * the whole document *
 [X]  - "Mus musculus bone morphogenetic protein receptor type 1a (Bmpr1a) mRNA, complete cds.", EMBL, (20030903), Database accession no. AY365062, URL: EBI, XP002468920 [X] 1,2,4,6-8,29-32,36 * the whole document *
 [T]  - DEWULF N ET AL, "DISTINCT SPATIAL AND TEMPORAL EXPRESSION PATTERNS OF TWO TYPE I RECEPTORS FOR BONE MORPHOGENETIC PROTEINS DURING MOUSE EMBRYOGENESIS", ENDOCRINOLOGY, BALTIMORE, MD, US, (19950601), vol. 136, no. 6, ISSN 0013-7227, pages 2652 - 2663, XP000611730 [T] * the whole document *

DOI:   http://dx.doi.org/10.1210/en.136.6.2652
 [T]  - DIJKE TEN P ET AL, "IDENTIFICATION OF TYPE I RECEPTORS FOR OSTEOGENIC PROTEIN-1 AND BONE MORPHOGENETIC PROTEIN-4", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, (19940624), vol. 269, no. 25, ISSN 0021-9258, pages 16985 - 16988, XP000611465 [T] * the whole document *
 [A]  - HE, W.H. ET AL.;, "Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family", DEVELOPMENTAL DYNAMICS, US, (199302), vol. 196, no. 2, pages 133 - 142, XP002468917 [A] * the whole document *
 [A]  - CUNNINGHAM, N.S. ET AL.;, "Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta1 m RNA expression", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., WASHINGTON US, (199212), vol. 89, pages 11740 - 11744, XP002468918 [A] * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.89.24.11740
 [PX]  - DIJKE TEN P ET AL, "ACTIVIN RECEPTOR-LIKE KINASES: A NOVEL SUBCLASS OF CELL-SURFACE RECEPTORS WITH PREDICTED SERINE/THREONINE KINASE ACTIVITY", ONCOGENE, BASINGSTOKE, HANTS, GB, (19931001), vol. 8, no. 10, ISSN 0950-9232, pages 2879 - 2887, XP000611724 [PX] 1,2,4,6-8,29-32,36 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.